APA (7th ed.) Citation

Niederberger-Leppin, V., & Pfaar, O. (2018). Safety and efficacy of immunotherapy with the recombinant B-cell epitope-based grass pollen vaccine BM32. The journal of allergy and clinical immunology, 142(2), . https://doi.org/10.1016/j.jaci.2017.09.052

Chicago Style (17th ed.) Citation

Niederberger-Leppin, Verena, and Oliver Pfaar. "Safety and Efficacy of Immunotherapy with the Recombinant B-cell Epitope-based Grass Pollen Vaccine BM32." The Journal of Allergy and Clinical Immunology 142, no. 2 (2018). https://doi.org/10.1016/j.jaci.2017.09.052.

MLA (9th ed.) Citation

Niederberger-Leppin, Verena, and Oliver Pfaar. "Safety and Efficacy of Immunotherapy with the Recombinant B-cell Epitope-based Grass Pollen Vaccine BM32." The Journal of Allergy and Clinical Immunology, vol. 142, no. 2, 2018, https://doi.org/10.1016/j.jaci.2017.09.052.